BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Serra N, Di Carlo P, Gulotta G, d' Arpa F, Giammanco A, Colomba C, Melfa G, Fasciana T, Sergi C. Bactibilia in women affected with diseases of the biliary tract and pancreas. A STROBE guidelines-adherent cross-sectional study in Southern Italy. J Med Microbiol. 2018;67:1090-1095. [PMID: 29975626 DOI: 10.1099/jmm.0.000787] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Sergi C, Villanacci V, Carroccio A. Non-celiac wheat sensitivity: rationality and irrationality of a gluten-free diet in individuals affected with non-celiac disease: a review. BMC Gastroenterol 2021;21:5. [PMID: 33407153 DOI: 10.1186/s12876-020-01568-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Wheatley RC, Kilgour E, Jacobs T, Lamarca A, Hubner RA, Valle JW, McNamara MG. Potential influence of the microbiome environment in patients with biliary tract cancer and implications for therapy. Br J Cancer 2021. [PMID: 34663949 DOI: 10.1038/s41416-021-01583-8] [Reference Citation Analysis]
3 Serra N, Colomba C, Di Carlo P, Palermo G, Fasciana T, Giammanco A, Novo G Jr, Rea T, Marino MM, Argano V, Sergi C. Infective Endocarditis: Preliminary Results of a Cohort Study in the Southern Italian Population. Cureus 2020;12:e8338. [PMID: 32617213 DOI: 10.7759/cureus.8338] [Reference Citation Analysis]
4 Nalluri H, Jensen E, Staley C. Role of biliary stent and neoadjuvant chemotherapy in the pancreatic tumor microbiome. BMC Microbiol 2021;21:280. [PMID: 34656097 DOI: 10.1186/s12866-021-02339-3] [Reference Citation Analysis]
5 Abdul Rahman R, Lamarca A, Hubner RA, Valle JW, McNamara MG. The Microbiome as a Potential Target for Therapeutic Manipulation in Pancreatic Cancer. Cancers (Basel) 2021;13:3779. [PMID: 34359684 DOI: 10.3390/cancers13153779] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zhang Z, Tang H, Chen P, Xie H, Tao Y. Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome. Signal Transduct Target Ther 2019;4:41. [PMID: 31637019 DOI: 10.1038/s41392-019-0074-5] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 17.7] [Reference Citation Analysis]
7 Serra N, Di Carlo P, D'Arpa F, Battaglia E, Fasciana T, Gulotta G, Maida CM, Rodolico V, Giammanco A, Sergi C. Human bile microbiota: A retrospective study focusing on age and gender. J Infect Public Health 2021;14:206-13. [PMID: 33486377 DOI: 10.1016/j.jiph.2020.11.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Monti M, Torri A, Amadori E, Rossi A, Bartolini G, Casadei C, Frassineti GL. Aeromonas veronii biovar veronii and sepsis-infrequent complication of biliary drainage placement: A case report. World J Clin Cases 2019; 7(6): 759-764 [PMID: 30968041 DOI: 10.12998/wjcc.v7.i6.759] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
9 Luo W, Cao Z, Qiu J, Liu Y, Zheng L, Zhang T. Novel Discoveries Targeting Pathogenic Gut Microbes and New Therapies in Pancreatic Cancer: Does Pathogenic E. coli Infection Cause Pancreatic Cancer Progression Modulated by TUBB/Rho/ROCK Signaling Pathway? A Bioinformatic Analysis. Biomed Res Int 2020;2020:2340124. [PMID: 32461969 DOI: 10.1155/2020/2340124] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Wei MY, Shi S, Liang C, Meng QC, Hua J, Zhang YY, Liu J, Zhang B, Xu J, Yu XJ. The microbiota and microbiome in pancreatic cancer: more influential than expected. Mol Cancer 2019;18:97. [PMID: 31109338 DOI: 10.1186/s12943-019-1008-0] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 17.7] [Reference Citation Analysis]
11 Qin H, Yuan B, Huang W, Wang Y. Utilizing Gut Microbiota to Improve Hepatobiliary Tumor Treatments: Recent Advances. Front Oncol 2022;12:924696. [DOI: 10.3389/fonc.2022.924696] [Reference Citation Analysis]
12 Di Carlo P, Serra N, D'Arpa F, Agrusa A, Gulotta G, Fasciana T, Rodolico V, Giammanco A, Sergi C. The microbiota of the bilio-pancreatic system: a cohort, STROBE-compliant study. Infect Drug Resist 2019;12:1513-27. [PMID: 31354308 DOI: 10.2147/IDR.S200378] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
13 Bellotti R, Speth C, Adolph TE, Lass-Flörl C, Effenberger M, Öfner D, Maglione M. Micro- and Mycobiota Dysbiosis in Pancreatic Ductal Adenocarcinoma Development. Cancers (Basel) 2021;13:3431. [PMID: 34298645 DOI: 10.3390/cancers13143431] [Reference Citation Analysis]
14 Merali N, Chouari T, Kayani K, Rayner CJ, Jiménez JI, Krell J, Giovannetti E, Bagwan I, Relph K, Rockall TA, Dhillon T, Pandha H, Annels NE, Frampton AE. A Comprehensive Review of the Current and Future Role of the Microbiome in Pancreatic Ductal Adenocarcinoma. Cancers 2022;14:1020. [DOI: 10.3390/cancers14041020] [Reference Citation Analysis]
15 Sergi C, Di Carlo P, Gulotta G, D'arpa F. Biliary microbiota in pancreatic cancer. HPB 2019;21:1790. [DOI: 10.1016/j.hpb.2019.06.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]